Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: ValuEngine, Inc.
Provider: S&P Capital IQ Quantitative Report
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Avanir Pharmaceuticals Inc gives Q1 2014 revenue guidance above analysts' estimates

Monday, 13 Jan 2014 08:00am EST 

Avanir Pharmaceuticals Inc:Sees Q1 2014 total gross revenues of about $34.6 million (Non-GAAP).Q1 2014 revenue of $24.1 million - Thomson Reuters I/B/E/S Estimates. 

Company Quote

-0.43 -3.26%
10:42am EDT